The antitrust agency paused its lawsuit against the pharmacy benefit manager while the two discuss a proposed consent ...

Grocery chain Albertsons, which offers pharmacies, is suing the Cigna-owned pharmacy benefit manager Express Scripts for at ...

The Federal Trade Commission (FTC) and Evernorth may be on the cusp of a settlement to resolve allegations that the company's ...

Cigna signed a definitive agreement to acquire Express Scripts for $67 billion in cash and stock, including assumption of $15 billion in Express Scripts debt. Here are five things to know about the ...

“Together with Express Scripts, Cigna will further accelerate our strategy of Go Deeper, Go Local and Go Beyond by improving affordability and choice, expanding our distribution reach, and further ...

A pharmacist retrieves a a medication. (Joe Raedle/Getty Images.) The owner of one of the three largest pharmacy middlemen in the United States last week filed suit to quash an attempt by the Federal ...

Cigna subsidiary Express Scripts Inc. claimed the Federal Trade Commission's July interim report—which claims middlemen have driven up prescription drug costs and exacerbated independent pharmacies—is ...

"The FTC has taken unconstitutional actions in publishing a report that ignores the evidence provided by our company and other [pharmacy benefit managers]," said Andrea Nelson, Cigna Group's chief ...

Dec. 19--New Jersey regulators have approved the $67 billion acquisition of Express Scripts Holding Co. by Cigna Corp., the last state to give the green light to the deal, the Bloomfield health ...

Cigna Corp. agreed to buy Express Scripts Holding in an about $54 billion deal that builds on the rapid transformation of the health-care business as companies and consumers chafe at rising costs. The ...

The Cigna Group’s CI pharmacy benefits manager, Express Scripts, recently partnered with CPESN USA to enhance access to comprehensive care at independent pharmacies. CPESN USA is a network of pharmacy ...

Cigna's pharmacy benefit manager Express Scripts has filed a lawsuit against the FTC over the agency's recent report on PBMs, which highlighted their contribution to soaring drug prices in the U.S.